While SLC7A11 indicates responsiveness quite well for tumor entities, we noticed that the correlation between SLC7A11 expression and APR-246/PRIMA-1 sensitivity (IC50) was reduced in neuroblastoma cell lines (Pearson correlation coefficient of 0.145, Figure 3a). The gene discussed is SLC7A11; the disease is neoplasm.